Literature DB >> 2467683

The effect of intensity of administered treatment on the outcome of germ cell tumours treated with POMB/ACE chemotherapy.

S M Crawford1, E S Newlands, R H Begent, G J Rustin, K D Bagshawe.   

Abstract

In order to assess the importance of the intensity of administration of chemotherapy in the management of advanced germ cell tumours we have calculated indices of chemotherapy. These have been used to compare the treatment given to patients who subsequently relapsed with matched controls who did not relapse. Two of these indices (alpha and beta) are derived from the doses of drugs whose dose is varied (cisplatinum, methotrexate and etoposide). These indices showed significant variation between cases and controls. Indices gamma and delta are derived from drugs whose dose is not varied. They showed no significant differences between the two groups. These results emphasise the importance of ensuring that patients with these curable cancers receive adequate doses of chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2467683      PMCID: PMC2246998          DOI: 10.1038/bjc.1989.49

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  9 in total

1.  Have new aggressive chemotherapy regimens improved results in advanced germ cell tumors?

Authors:  L H Einhorn
Journal:  Eur J Cancer Clin Oncol       Date:  1986-11

2.  Prognostic factors in advanced non-seminomatous germ-cell testicular tumours: results of a multicentre study. Report from the Medical Research Council Working Party on Testicular Tumours.

Authors: 
Journal:  Lancet       Date:  1985-01-05       Impact factor: 79.321

3.  Current optimum management of anaplastic germ cell tumours of the testis and other sites.

Authors:  E S Newlands; K D Bagshawe; R H Begent; G J Rustin; S M Crawford; L Holden
Journal:  Br J Urol       Date:  1986-06

4.  Time-dose factors in chemotherapy: expanding the concept of dose-intensity.

Authors:  A J Dembo
Journal:  J Clin Oncol       Date:  1987-05       Impact factor: 44.544

Review 5.  The importance of dose intensity in chemotherapy of metastatic breast cancer.

Authors:  W Hryniuk; H Bush
Journal:  J Clin Oncol       Date:  1984-11       Impact factor: 44.544

6.  A dose and time response analysis of the treatment of Hodgkin's disease with MOPP chemotherapy.

Authors:  P Carde; F R MacKintosh; S A Rosenberg
Journal:  J Clin Oncol       Date:  1983-02       Impact factor: 44.544

7.  Dose: a critical factor in cancer chemotherapy.

Authors:  E Frei; G P Canellos
Journal:  Am J Med       Date:  1980-10       Impact factor: 4.965

8.  Further advances in the management of malignant teratomas of the testis and other sites.

Authors:  E S Newlands; R H Begent; G J Rustin; D Parker; K D Bagshawe
Journal:  Lancet       Date:  1983-04-30       Impact factor: 79.321

9.  Dose intensity analysis of chemotherapy regimens in ovarian carcinoma.

Authors:  L Levin; W M Hryniuk
Journal:  J Clin Oncol       Date:  1987-05       Impact factor: 44.544

  9 in total
  3 in total

1.  Calculation of received dose intensity for combinations of drugs using small-cell lung carcinoma treatment regimens as examples.

Authors:  G L Wampler; J G Fryer
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

Review 2.  The role of surgery in metastatic testicular germ cell tumours (GCT).

Authors:  E S Newlands; K W Reynolds
Journal:  Br J Cancer       Date:  1989-06       Impact factor: 7.640

Review 3.  Germ cell tumour chemotherapy.

Authors:  A Horwich
Journal:  Br J Cancer       Date:  1989-02       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.